|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,700 KRW | 0.00% |
|
-3.88% | -17.15% |
PanGen Biotech Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 299.52 million compared to KRW 328.98 million a year ago. Net loss was KRW 1,292.75 million compared to KRW 900.43 million a year ago.
Basic loss per share from continuing operations was KRW 121 compared to KRW 84 a year ago. Basic loss per share was KRW 121 compared to KRW 84 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.15% | 48.08M | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
PANGEN BIOTECH INC. 
